Discovery contributes to better understanding of acquired resistance to combination drug treatment in cancer
Monday, September 5, 2016 - 14:31
in Health & Medicine
A new study on acquired resistance (AQR) to combination drug treatment in cancer has been conducted, with results demonstrating that the mechanisms of AQR for the combination drugs were different from that of the individual drugs. The findings from this study could potentially contribute to reducing AQR to combination drug treatment in cancer.